MHRA Class 2 Medicines Recall: Mefenamic Acid 500mg film coated tablets (Quadrant Pharmaceuticals Ltd)

Class 2 Medicines recall: Mefenamic Acid 500mg film coated tablets (Quadrant Pharmaceuticals Ltd)

Drug alert number: EL (22) A/23

Date issued: 17th May 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:

Mefenamic Acid 500mg film coated tablets (Quadrant Pharmaceuticals Ltd)

Quadrant Pharmaceuticals Ltd are recalling a specific batch of Mefenamic Acid 500mg Film-Coated Tablets as a precautionary measure, due to observations of a defective layer of film coating in some tablets, resulting in the tablet core being partially exposed.

Batch Number Company’s Reference Expiry Date Pack Size First Distributed
107082 6949U 04/2023 30 03/2022

Advice for healthcare professionals

Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Full drug alert can be viewed here.

Company contacts for further information

For more information, medical or supply enquiries, please contact joanne.fishwick@maxearn.co.uk or radoslaw.bandomir@maxearn.co.uk

Support the call for more funding by recording information about the informal advice you provide to patients over just one day.

Click Here